Compare OVID & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | TRTX |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.5M | 660.2M |
| IPO Year | 2017 | 2015 |
| Metric | OVID | TRTX |
|---|---|---|
| Price | $2.69 | $7.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $4.60 | ★ $9.83 |
| AVG Volume (30 Days) | ★ 1.4M | 679.8K |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 11.55% |
| EPS Growth | ★ 3.90 | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | ★ $7,252,000.00 | N/A |
| Revenue This Year | N/A | $8.78 |
| Revenue Next Year | $19.34 | $4.14 |
| P/E Ratio | ★ N/A | $40.26 |
| Revenue Growth | ★ 1181.27 | N/A |
| 52 Week Low | $1.12 | $7.57 |
| 52 Week High | $3.11 | $9.51 |
| Indicator | OVID | TRTX |
|---|---|---|
| Relative Strength Index (RSI) | 46.31 | 29.88 |
| Support Level | $2.60 | N/A |
| Resistance Level | $2.77 | $8.74 |
| Average True Range (ATR) | 0.13 | 0.13 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 10.29 | 2.06 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.